Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier W Sanders

Showing results (51-60 of 325) with videos related to

Pageof 33
Sort By:
Journal of Virology|October 28, 2004
Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitorChris E Baldwin, Rogier W Sanders, Yiqun Deng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2011
HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentationThijs van Montfort, Dirk Eggink, Maikel Boot, et al.
Virology|March 20, 2012
V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and VicrivirocReem Berro, Per Johan Klasse, Martin R Jakobsen, et al.
Journal of Virology|March 27, 2015
What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure?Marina R Alexander, Rajesh Ringe, Rogier W Sanders, et al.
Biomolecules|October 30, 2015
Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein TrimerKwinten Sliepen, Thijs van Montfort, Gabriel Ozorowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 11, 2015
Reactivation of Neutralized HIV-1 by Dendritic Cells Is Dependent on the Epitope Bound by the AntibodyThijs van Montfort, Adri A M Thomas, Przemek M Krawczyk, et al.
Journal of Virology|April 25, 2008
Selection of T1249-resistant human immunodeficiency virus type 1 variantsDirk Eggink, Christopher E Baldwin, Yiqun Deng, et al.
Nature Communications|February 17, 2019
Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptideSonu Kumar, Anita Sarkar, Pavel Pugach, et al.
Journal of Virology|January 28, 2021
Production of HIV-1 Env-specific antibodies mediating innate immune functions depends on cognate IL-21- secreting CD4+ T cellsJernej Pušnik, Stephanie Fischinger, Ulf Dittmer, et al.
Chembiochem : a European Journal of Chemical Biology|June 1, 2022
Conjugation of a Toll-Like Receptor Agonist to Glycans of an HIV Native-Like Envelope Trimer Preserves Neutralization EpitopesZeshi Li, Ronald Derking, Wen-Hsin Lee, et al.
Pageof 33

Showing results (51-60 of 325) with videos related to

Sort By:
Pageof 33
Journal of Virology|October 28, 2004
Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitorChris E Baldwin, Rogier W Sanders, Yiqun Deng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2011
HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentationThijs van Montfort, Dirk Eggink, Maikel Boot, et al.
Virology|March 20, 2012
V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and VicrivirocReem Berro, Per Johan Klasse, Martin R Jakobsen, et al.
Journal of Virology|March 27, 2015
What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure?Marina R Alexander, Rajesh Ringe, Rogier W Sanders, et al.
Biomolecules|October 30, 2015
Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein TrimerKwinten Sliepen, Thijs van Montfort, Gabriel Ozorowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 11, 2015
Reactivation of Neutralized HIV-1 by Dendritic Cells Is Dependent on the Epitope Bound by the AntibodyThijs van Montfort, Adri A M Thomas, Przemek M Krawczyk, et al.
Journal of Virology|April 25, 2008
Selection of T1249-resistant human immunodeficiency virus type 1 variantsDirk Eggink, Christopher E Baldwin, Yiqun Deng, et al.
Nature Communications|February 17, 2019
Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptideSonu Kumar, Anita Sarkar, Pavel Pugach, et al.
Journal of Virology|January 28, 2021
Production of HIV-1 Env-specific antibodies mediating innate immune functions depends on cognate IL-21- secreting CD4+ T cellsJernej Pušnik, Stephanie Fischinger, Ulf Dittmer, et al.
Chembiochem : a European Journal of Chemical Biology|June 1, 2022
Conjugation of a Toll-Like Receptor Agonist to Glycans of an HIV Native-Like Envelope Trimer Preserves Neutralization EpitopesZeshi Li, Ronald Derking, Wen-Hsin Lee, et al.
Pageof 33